Human Papillomavirus–Related Cancer in People With HIV and Solid Organ Transplant Recipients - Report - MDSpire

Human Papillomavirus–Related Cancer in People With HIV and Solid Organ Transplant Recipients

  • By

  • Eva Meglic

  • Alexander Ploner

  • Yunyang Deng

  • Johanna Brännström

  • Olof Elvstam

  • Fredrik Månsson

  • Åsa Mellgren

  • Jiayao Lei

  • Christina Carlander

  • June 30, 2026

  • 0 min

Share

Cancer Associated with Human Papillomavirus in Individuals with HIV and Recipients of Solid Organ Transplants

Overview

This study investigates the odds of HPV-related cancers in individuals with HIV and solid organ transplant recipients compared to unexposed individuals, utilizing nationwide Swedish registers to analyze clinical and sociodemographic factors influencing cancer risk.

Background

Human papillomavirus (HPV) is a leading cause of various cancers, particularly in immunocompromised populations such as individuals with HIV and solid organ transplant recipients. These groups are at an elevated risk for HPV-related cancers due to their weakened immune systems, which hinder HPV clearance.

Data Highlights

No numerical data or trial data provided in the source material.

Key Findings

  • HPV is linked to nearly all cervical cancer cases and significantly contributes to other cancers.
  • Individuals with HIV and solid organ transplant recipients face higher risks of HPV-related cancers.
  • Persistent HPV infections are more common in populations with compromised immune systems.
  • Behavioral and sociodemographic factors influence cancer risk among these groups.
  • Previous studies indicate a lack of direct comparisons between cancer risks in individuals with HIV and solid organ transplant recipients.

Clinical Implications

Healthcare providers should be aware of the increased risk of HPV-related cancers in individuals with HIV and solid organ transplant recipients. This knowledge can inform screening practices and preventive measures tailored to these high-risk populations.

Conclusion

The study highlights the importance of understanding HPV-related cancer risks in immunocompromised individuals, which can guide future research and clinical practices.

Related Resources & Content

  1. The ASCO Post, 2015 -- HIV-Related Lymphoma Can Be Safely Treated With Transplant Related Articles
  2. The ASCO Post, 2024 -- RP1 Immunotherapy in Solid Organ Transplant Recipients With Skin Cancer
  3. Infection, 2026 -- Challenges and limitations of anal cancer and precancer screening among people with HIV in a real-world setting
  4. The ASCO Post, 2026 -- Risk of Subsequent Cancer in Solid Organ Transplant Recipients With Pretransplant Cancer History
  5. NIH -- Human Papillomavirus Disease: Adult and Adolescent OIs
  6. International Journal of Cancer, 2024 -- International Anal Neoplasia Society's consensus guidelines for anal cancer screening
  7. CDC HPV Vaccine Recommendations
  8. Screening for Cervical Cancer | ACOG
  9. Human Papillomavirus Disease: Adult and Adolescent OIs | NIH
  10. International Anal Neoplasia Society's consensus guidelines for anal cancer screening - Stier - 2024 - International Journal of Cancer - Wiley Online Library
  11. Screening for Anal Dysplasia and Cancer in Adults With HIV - Clinical Guidelines Program
  12. Human papillomavirus infection in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice - Chin‐Hong - 2019 - Clinical Transplantation - Wiley Online Library
  13. Cancer-related mortality among solid organ transplant recipients: systematic review and meta-analysis
  14. International Anal Neoplasia Society's consensus guidelines for anal cancer screening

Original Source(s)

Related Content